NRG
AVNS

Nemes Rush Group’s Avanos Medical AVNS Stock Holding History

Nemes Rush Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27K Hold
51
– – ﹤0.01% 837
2026
Q1 		$715 Hold
51
– – ﹤0.01% 853
2025
Q4 		$573 Hold
51
– – ﹤0.01% 860
2025
Q3 		$590 Hold
51
– – ﹤0.01% 656
2025
Q2 		$624 Hold
51
– – ﹤0.01% 681
2025
Q1 		$731 Hold
51
– – ﹤0.01% 666
2024
Q4 		$812 Hold
51
– – ﹤0.01% 671
2024
Q3 		$1.01K Hold
51
– – ﹤0.01% 546
2024
Q2 		$1.02K Hold
51
– – ﹤0.01% 555
2024
Q1 		$1.02K Hold
51
– – ﹤0.01% 603
2023
Q4 		$1.14K Hold
51
– – ﹤0.01% 587
2023
Q3 		$1.03K Sell
51
-26
-34% -$589 ﹤0.01% 583
2023
Q2 		$1.97K Buy
+77
New +$2.03K ﹤0.01% 570

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nemes Rush Group's AVNS Position: Q2 2026 in Review

Nemes Rush Group held its Avanos Medical (AVNS) position steady in Q2 2026 at 51 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Nemes Rush Group first reported a position in AVNS in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.97K in Q2 2023. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Nemes Rush Group held 51 shares of Avanos Medical worth $1.27K as of Q2 2026.
  • Nemes Rush Group left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #837 holding.
  • Nemes Rush Group first reported a position in Avanos Medical in Q2 2023 and has held it in 13 quarters since.
  • Nemes Rush Group's Avanos Medical position peaked at $1.97K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.